2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.0998

Efficacy of LMWH in preventing adverse neonatal outcomes in isolated oligohydramnios

View Poster Contact Presenter

Poster Presenter

hasina sadiq

Authors

Hasina Sadiq, Filza Habib, Maria Aslam, Shafaq Fatima

Affiliations

University Hospital Birmingham, Shifa College of Medicine, Queens Elizebeth Hospital, University Hospital Birmingham NHS Foundation Trust, krl hospital Islamabad, University of Birmingham NHS Foundation trust, University Hospital Birminghan NHS foundation trust

Part of Topic

High risk pregnancy

EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN PREVENTING ADVERSE NEONATAL OUTCOMES BY INCREASING LIQUOR VOLUME IN ISOLATED SECOND THIRD TRIMESTER OLIGOHYDRAMNIOS

INTRODUCTION

Oligohydramnios is relatively common pregnancy-related complication.

Its incidence varies from 0.5-1.5% of the population.

It is usually found to be associated with intrauterine growth retardation (IUGR) and various other chronic ailments.

Current Challenge:

In patients with oligohydramnios, the placenta has a dysfunctional flow.

Heparin helps to improve blood flow through the placenta hence liquor volume is substantially improved.

OBJECTIVE

To study the efficacy of LMWH in increasing AFI in isolated second and third trimester

oligohydramnios.

To study the feto-maternal outcomes including

·Gestational age at the time of diagnosis

·Gestational age at the time of delivery

·Mode of delivery

·Weight of baby at birth

·Apgar score

·NICU Admission

·APH

·PIH/Preeclampsia